THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Clearline Capital LP's Holding History (CIK: 0001600136)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021

Shares 577,800 Value ($000) $4,276 Avg Close $11.19 Range $6.10 - $15.01

Q2 2019

Shares 37,258 Value ($000) $608 Avg Close $20.26 Range $15.18 - $25.38

Q3 2015

Shares 516,804 Value ($000) $5,680 Avg Close $12.73 Range $10.69 - $15.00

Q2 2015

Shares 487,992 Value ($000) $6,354 Avg Close $15.51 Range $12.52 - $18.92

Q1 2015

Shares 243,706 Value ($000) $4,228 Avg Close $18.33 Range $14.59 - $22.00

Q4 2014

Shares 250,550 Value ($000) $3,738 Avg Close $17.42 Range $13.11 - $24.06

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2021	577,800	$4,276	$11.19	$6.10 - $15.01
Q2 2019	37,258	$608	$20.26	$15.18 - $25.38
Q3 2015	516,804	$5,680	$12.73	$10.69 - $15.00
Q2 2015	487,992	$6,354	$15.51	$12.52 - $18.92
Q1 2015	243,706	$4,228	$18.33	$14.59 - $22.00
Q4 2014	250,550	$3,738	$17.42	$13.11 - $24.06